news archive
LG.Philips
LCD Files Patent Infringement Lawsuit Against CPT
Seoul, South
Korea, Sept. 3 - LG.Philips LCD Co., Ltd. today announced
that it has filed a patent infringement lawsuit against
Chunghwa Picture Tubes, Ltd (CPT), Tatung Co., and Tatung
Co. of America in the United States Federal Court in Los
Angeles, California. The complaint and suit allege that CPT
has infringed on six of LG.Philips LCD's U.S. patents
related to the company's TFT-LCD technology (U.S. Patent No.
4,624,737, No. 5,825,449, No. 6,373,537, No. 6,020,942, No.
6,002,457 and No. 5,926,237). As one of the world's largest
producers of TFT-LCDs, LG.Philips LCD has an extensive
technology patent portfolio. The company filed this lawsuit
to protect its valuable intellectual property (IP), only
after CPT refused to cease its infringing activities or
negotiate an amicable resolution to the dispute, LG.Philips
said in today's press release.
Information:
Bruce Berkoff, EVP, Marketing, LG.Philips LCD. email: bruce@lgphilips-lcd.com,
www.lgphilips-lcd.com.
HoloTouch
Unveils "Controls that Float in Thin Air"
Darien,
Connecticut, September 12 - HoloTouch, Inc. announced today
that it will introduce its new holographic control
technology into operating rooms and other sterile
environments. HoloTouch™ patented technology enables
controls that float in thin air, allowing healthcare
personnel to manage a wide variety of electronic devices by
simply "touching" 3D holographic images floating
at a convenient location.
"Surgeons
often need to view footage from the beginning of a medical
procedure. With HoloTouch, the controls are contained in
holographic images, projected directly in front of the
surgeon. The surgeon's hands may be covered in blood, but,
since the "button" to be pushed consists only of
beams of light, there are no contamination issues,"
said HoloTouch inventor and President R. Douglas McPheters.
John D.
Fisher, M.D., Director of Arrhythmia Services and Professor
of Medicine at Albert Einstein College of Medicine, praised
the new technology as a significant improvement over
existing methods. "During angioplasties, pacemaker
implantations, and other cardiac procedures we must be able
to quickly see the visual record of the patient's condition
at various times since the beginning of the procedure. With
HoloTouch, the surgeon is in direct control of this visual
record, eliminating the delay and risk of misinterpretation
that exists under present systems," Dr. Fisher said.
The company
is speaking with several manufacturers interested in
licensing HoloTouch for use in high-end audio-visual
equipment, car phones, "factory floor"
applications, military hardware, and other electronic
devices, McPheters said.
Information: Tel:
(203) 656-9686, email: rdmcpheters@holotouch.biz,
www.holotouch.biz.
